[HTML] springer.comFull View

[HTML][HTML] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips, BH Shakur… - Respiratory …, 2005 - Springer
Background Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
被引用次数：125 相关文章

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips, BH Shakur… - Respiratory …, 2005 - go.gale.com
Background Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
[PDF] core.ac.uk

[PDF][PDF] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips, BH Shakur… - Respiratory …, 2005 - core.ac.uk
Background: Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
[HTML] nih.gov

[HTML][HTML] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips… - Respiratory …, 2005 - ncbi.nlm.nih.gov
Background Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease.

NW Morrell, MA Higham, PG Phillips… - Respiratory …, 2005 - search.ebscohost.com
Background: Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
[PDF] scienceopen.com

[PDF][PDF] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips… - Respiratory …, 2005 - scienceopen.com
Background: Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
[PDF] researchgate.net

[PDF][PDF] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips… - Respiratory …, 2005 - researchgate.net
Background: Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips, BH Shakur… - 2005 - pubmed.ncbi.nlm.nih.gov
Background Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
[PDF] cyberleninka.org

[PDF][PDF] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips… - Respiratory …, 2005 - cyberleninka.org
Background: Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …
[PDF] psu.edu

[PDF][PDF] Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease

NW Morrell, MA Higham, PG Phillips, BH Shakur… - Respiratory …, 2005 - Citeseer
Background: Morbidity in COPD results from a combination of factors including hypoxia-
induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal …